Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Effect of cationic liposomes on BCG trafficking and vaccine-induced immune responses following a subcutaneous immunization in mice.

Derrick SC, Yang A, Parra M, Kolibab K, Morris SL.

Vaccine. 2015 Jan 1;33(1):126-32. doi: 10.1016/j.vaccine.2014.11.004. Epub 2014 Nov 15.

PMID:
25448108
2.

Intranasal administration of Mycobacterium bovis BCG induces superior protection against aerosol infection with Mycobacterium tuberculosis in mice.

Derrick SC, Kolibab K, Yang A, Morris SL.

Clin Vaccine Immunol. 2014 Oct;21(10):1443-51. doi: 10.1128/CVI.00394-14. Epub 2014 Aug 20.

3.

Time to detection of Mycobacterium tuberculosis using the MGIT 320 system correlates with colony counting in preclinical testing of new vaccines.

Kolibab K, Yang A, Parra M, Derrick SC, Morris SL.

Clin Vaccine Immunol. 2014 Mar;21(3):453-5. doi: 10.1128/CVI.00742-13. Epub 2013 Dec 26.

4.

Immunogenicity and protective efficacy of novel Mycobacterium tuberculosis antigens.

Derrick SC, Yabe IM, Yang A, Kolibab K, Hollingsworth B, Kurtz SL, Morris S.

Vaccine. 2013 Sep 23;31(41):4641-6. doi: 10.1016/j.vaccine.2013.07.032. Epub 2013 Jul 30.

PMID:
23906890
5.

Molecular analysis of non-specific protection against murine malaria induced by BCG vaccination.

Parra M, Liu X, Derrick SC, Yang A, Tian J, Kolibab K, Kumar S, Morris SL.

PLoS One. 2013 Jul 4;8(7):e66115. doi: 10.1371/journal.pone.0066115. Print 2013.

6.

Characterization of an intracellular ATP assay for evaluating the viability of live attenuated mycobacterial vaccine preparations.

Kolibab K, Derrick SC, Jacobs WR, Morris SL.

J Microbiol Methods. 2012 Sep;90(3):245-9. doi: 10.1016/j.mimet.2012.05.015. Epub 2012 May 28.

PMID:
22652432
7.

Formulation of a mmaA4 gene deletion mutant of Mycobacterium bovis BCG in cationic liposomes significantly enhances protection against tuberculosis.

Derrick SC, Dao D, Yang A, Kolibab K, Jacobs WR, Morris SL.

PLoS One. 2012;7(3):e32959. doi: 10.1371/journal.pone.0032959. Epub 2012 Mar 19.

8.

Malaria infections do not compromise vaccine-induced immunity against tuberculosis in mice.

Parra M, Derrick SC, Yang A, Tian J, Kolibab K, Oakley M, Perera LP, Jacobs WR, Kumar S, Morris SL.

PLoS One. 2011;6(12):e28164. doi: 10.1371/journal.pone.0028164. Epub 2011 Dec 19.

9.

Sensitivity to isoniazid of Mycobacterium bovis BCG strains and BCG disseminated disease isolates.

Kolibab K, Derrick SC, Morris SL.

J Clin Microbiol. 2011 Jun;49(6):2380-1. doi: 10.1128/JCM.00648-11. Epub 2011 Apr 20. No abstract available.

10.

Highly persistent and effective prime/boost regimens against tuberculosis that use a multivalent modified vaccine virus Ankara-based tuberculosis vaccine with interleukin-15 as a molecular adjuvant.

Kolibab K, Yang A, Derrick SC, Waldmann TA, Perera LP, Morris SL.

Clin Vaccine Immunol. 2010 May;17(5):793-801. doi: 10.1128/CVI.00006-10. Epub 2010 Mar 31.

11.

A practical in vitro growth inhibition assay for the evaluation of TB vaccines.

Kolibab K, Parra M, Yang AL, Perera LP, Derrick SC, Morris SL.

Vaccine. 2009 Dec 11;28(2):317-22. doi: 10.1016/j.vaccine.2009.10.047. Epub 2009 Oct 29.

PMID:
19879231
12.

Development of a murine mycobacterial growth inhibition assay for evaluating vaccines against Mycobacterium tuberculosis.

Parra M, Yang AL, Lim J, Kolibab K, Derrick S, Cadieux N, Perera LP, Jacobs WR, Brennan M, Morris SL.

Clin Vaccine Immunol. 2009 Jul;16(7):1025-32. doi: 10.1128/CVI.00067-09. Epub 2009 May 20.

13.

A multi-valent vaccinia virus-based tuberculosis vaccine molecularly adjuvanted with interleukin-15 induces robust immune responses in mice.

Perera PY, Derrick SC, Kolibab K, Momoi F, Yamamoto M, Morris SL, Waldmann TA, Perera LP.

Vaccine. 2009 Mar 26;27(15):2121-7. doi: 10.1016/j.vaccine.2009.01.132. Epub 2009 Feb 6.

14.

Early pulmonary cytokine and chemokine responses in mice immunized with three different vaccines against Mycobacterium tuberculosis determined by PCR array.

Lim J, Derrick SC, Kolibab K, Yang AL, Porcelli S, Jacobs WR, Morris SL.

Clin Vaccine Immunol. 2009 Jan;16(1):122-6. doi: 10.1128/CVI.00359-08. Epub 2008 Nov 26.

15.

The safety of post-exposure vaccination of mice infected with Mycobacterium tuberculosis.

Derrick SC, Perera LP, Dheenadhayalan V, Yang A, Kolibab K, Morris SL.

Vaccine. 2008 Nov 11;26(48):6092-8. doi: 10.1016/j.vaccine.2008.09.011. Epub 2008 Sep 20.

PMID:
18809446
16.

Mycobacterium bovis BCG immunization induces protective immunity against nine different Mycobacterium tuberculosis strains in mice.

Jeon BY, Derrick SC, Lim J, Kolibab K, Dheenadhayalan V, Yang AL, Kreiswirth B, Morris SL.

Infect Immun. 2008 Nov;76(11):5173-80. doi: 10.1128/IAI.00019-08. Epub 2008 Aug 18.

17.

Immune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults: analysis of the variable light chain repertoire.

Smithson SL, Kolibab K, Shriner AK, Srivastava N, Khuder S, Westerink MA.

Infect Immun. 2005 Nov;73(11):7477-84.

18.

Immune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults: analysis of the variable heavy chain repertoire.

Kolibab K, Smithson SL, Rabquer B, Khuder S, Westerink MA.

Infect Immun. 2005 Nov;73(11):7465-76.

19.

Immune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults. I. Antibody concentrations, avidity and functional activity.

Kolibab K, Smithson SL, Shriner AK, Khuder S, Romero-Steiner S, Carlone GM, Westerink MA.

Immun Ageing. 2005 Jun 27;2:10.

Supplemental Content

Loading ...
Support Center